Back to top

Avadel Pharmaceuticals Shifts to Nasdaq, Ends ADR Program

Avadel Pharmaceuticals (AVDL) has issued an announcement. Starting April 15, 2024, Avadel Pharmaceuticals will list its ordinary shares on the Nasd...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Avadel Pharmaceuticals PLC. (AVDL)